Burke Steven Keith 4
4 · Akebia Therapeutics, Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2024-02-29$1.58/sh−7,169$11,327→ 695,840 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.